Howard P. Walthall

Mr. Walthall is a seasoned Life Sciences executive with an extensive background in Regenerative Medicine, Orthopedics and Advanced Wound Care. During his career, he oversaw multiple highly successful product development projects and new product launches and led a growing company to successful exit by strategic acquisition. Mr. Walthall began his career in 2000 as an attorney at Burr & Forman LLP where he specialized in 10 intellectual property and technology-related litigation and transactional work. In 2011, Mr. Walthall became President and CEO of NuTech Spine, Inc. and later held concurrent President and CEO positions at NuTech Medical, Inc. and NuTech Spine Inc. ("NuTech"), companies specialized in the business of advanced surgical biologics and wound care. After a successful exit via the acquisition of NuTech by Organogenesis, Inc. ("Organogenensis"), Mr. Walthall became Executive Vice President, Strategy and Market Development at Organogenesis where he led Sales, Marketing and R&D for the Surgical and Sports Medicine (SSM) product lines. In 2020, Mr. Walthall founded and is now CEO of Lumiheal Therapeutics, Inc., a company which develops and commercializes a patented technology that uses fluorescent light energy (FLE) to heal chronic and acute wounds, burns, and surgical incisions. Mr. Walthall holds a Bachelor of Science in Engineering (B.S.E.) from Duke University, Durham, NC and a Juris Doctor (JD) from Samford University – Cumberland School of Law, Birmingham, AL.